Updates in US systemic lupus erythematosus epidemiology: Tales of two cities

Arthritis and Rheumatology

Volumn 66, Issue 2, 2014, Pages 242-245

  Bartels, Christie Michels ^a   Ramsey Goldman, Rosalind ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

COMPREHENSION; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH DISPARITY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INCIDENCE; INFECTIOUS COMPLICATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICALLY UNINSURED; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RACE DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; EPIDEMIOLOGICAL MONITORING; ETHNOLOGY; FEMALE; MALE; NOTE; REGISTER;

EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; REGISTRIES;

EID: 84896257642     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38240     Document Type: Editorial

References (29)

1. Duran S, Apte M, Alarcon GS. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007;99: 1196-8.
2. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010;69: 529-35.
3. Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, et al. The 1000 Canadian Faces of Lupus: determinants of disease outcome in a large multiethnic cohort. J Rheumatol 2009;36: 1200-8.
4. Bernatsky S, Linehan T, Hanly JG. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 2011;38: 1612-6.
5. Lim SS, Drenkard C, McCune WJ, Helmick CG, Gordon C, DeGuire P, et al. Population-based lupus registries: advancing our epidemiologic understanding. Arthritis Rheum 2009;61: 1462-6.
6. Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005;14: 862-6.
7. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42: 46-50.
8. Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al, and the Tri-Nation Study Group. The systemic lupus erythematosus Tri-Nation Study: cumulative indirect costs. Arthritis Rheum 2007;57: 64-70.
9. Zhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken) 2011;63: 751-60.
10. [published erratum appears in Arthritis Care Res (Hoboken) 2011;63:1074]
11. Buckalew VM Jr, Freedman BI. Reappraisal of the impact of race on survival in patients on dialysis. Am J Kidney Dis 2010;55: 1102-10.
12. Crews DC, Charles RF, Evans MK, Zonderman AB, Powe NR. Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2010;55: 992-1000.
13. Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006;15: 715-9.
14. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al, and the Systemic Lupus Erythematosus Quality Indicators Project Expert Panels. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 2009;61: 370-7.
15. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia Lupus Registry. Arthritis Rheumatol 2014;66: 357-68.
16. Somers EC, Marder W, Cagnoli P, Lewis EE, DeGuire P, Gordon C, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance Program. Arthritis Rheumatol 2014;66: 369-78.
17. Alonso MD, Martinez-Vazquez F, de Teran TD, Miranda-Filloy JA, Dierssen T, Blanco R, et al. Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus 2012; 21: 1135-48.
18. Lalani S, Pope J, de Leon F, Peschken C, and the Members of CaNIOS/1000 Faces of Lupus. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 Faces of Lupus study. J Rheumatol 2010;37: 38-44.
19. Somers EC, Thomas SL, Smeeth L, Schoonen WM, Hall AJ. Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis Rheum 2007;57: 612-8.
20. Yang N, Li H, Criswell LA, Gregersen PK, Alarcon-Riquelme ME, Kittles R, et al. Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum Genet 2005;118: 382-92.
21. Ng R, Bernatsky S, Rahme E. Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec. J Rheumatol 2013;40: 1334-6.
22. Ward MM. Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol 2013; 40: 1241-3.
23. Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis 2011;70: 1752-7.
24. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64: 2677-86.
25. Gladman DD, Ibanez D, Ruiz I, Urowitz MB. Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study. J Rheumatol 2013;40: 630-3.
26. Tonner C, Trupin L, Yazdany J, Criswell L, Katz P, Yelin E. Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010;62: 888-95.
27. Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012;156: 817-33.
28. Todd SR, Sommers BD. Overview of the uninsured in the United States: a summary of the 2012 Current Population Survey Report. Washington (DC): US Department of Health & Human Services; 2012. URL: http://aspe.hhs.gov/ health/reports/2012/uninsuredin theus/ib.shtml#who.
29. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15: 308-18.